Tag Archives: EV-077

Evolva concludes licensing of EV-077 to Serodus

Posted on by Isabelle Wymann

Evolva to license EV-077 to Serodus

Posted on by Isabelle Wymann

Evolva successfully discussed clinical development plans for EV-077 in diabetes patients with German regulatory authority

Posted on by Isabelle Wymann

Evolva’s EV-077 achieved objectives in first group of patients in Phase IIa trial

Posted on by Isabelle Wymann